• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

遗传性乳腺癌家系中不一致同胞对的研究及罕见 PMS1 变异体的分析。

Investigation of discordant sibling pairs from hereditary breast cancer families and analysis of a rare PMS1 variant.

机构信息

Department of Medicine Hematology-Oncology, UVM Medical Center, Burlington, VT, USA.

Department of Pathology and Laboratory Medicine, U-VM Larner College of Medicine, Burlington, VT, USA.

出版信息

Cancer Genet. 2022 Jan;260-261:30-36. doi: 10.1016/j.cancergen.2021.11.004. Epub 2021 Nov 15.

DOI:10.1016/j.cancergen.2021.11.004
PMID:34852986
Abstract

BACKGROUND

It is likely that additional genes for hereditary breast cancer can be identified using a discordant sib pair design. Using this design we identified individuals harboring a rare PMS1 c.605G>A variant previously predicted to result in loss of function.

OBJECTIVES

A family-based design and predictive algorithms were used to prioritize candidate variants possibly associated with an increased risk of hereditary breast cancer. Functional analyses were performed for one of the candidate variants, PMS1 c.605G>A.

METHODS

  1. 14 discordant sister-pairs from hereditary breast cancer families were identified. 2) Whole exome sequencing was performed and candidate risk variants identified. 3) A rare PMS variant was identified in 2 unrelated affected sisters but no unaffected siblings. 4) Functional analysis of this variant was carried out using targeted mRNA sequencing.

RESULTS

Genotype-phenotype correlation did not demonstrate tracking of the variant with cancer in the family. Functional analysis revealed no difference in exon 6 incorporation, which was validated by analyzing PMS1 allele specific expression.

CONCLUSIONS

The PMS1 c.605G>A variant did not segregate with disease, and there was no variant-dependent impact on PMS1 exon 6 splicing, supporting this variant is likely benign. Functional analyses are imperative to understanding the clinical significance of predictive algorithms.

摘要

背景

使用不一致的同胞对设计,可能会鉴定出更多遗传性乳腺癌的基因。使用该设计,我们鉴定出了携带有先前预测导致功能丧失的罕见 PMS1 c.605G>A 变异的个体。

目的

使用基于家族的设计和预测算法,优先考虑可能与遗传性乳腺癌风险增加相关的候选变异。对候选变异之一 PMS1 c.605G>A 进行了功能分析。

方法

1)从遗传性乳腺癌家族中鉴定出 14 对不一致的姐妹对。2)进行全外显子组测序并鉴定候选风险变异。3)在 2 位无血缘关系的受影响姐妹中发现了罕见的 PMS 变异,但在无血缘关系的兄弟姐妹中没有发现。4)使用靶向 mRNA 测序对该变体进行功能分析。

结果

基因型-表型相关性并未显示该变体与家族中癌症的关联性。功能分析显示,第 6 外显子的掺入没有差异,这通过分析 PMS1 等位基因特异性表达得到了验证。

结论

PMS1 c.605G>A 变体与疾病没有分离,并且该变体对 PMS1 外显子 6 剪接没有影响,支持该变体可能是良性的。功能分析对于理解预测算法的临床意义至关重要。

相似文献

1
Investigation of discordant sibling pairs from hereditary breast cancer families and analysis of a rare PMS1 variant.遗传性乳腺癌家系中不一致同胞对的研究及罕见 PMS1 变异体的分析。
Cancer Genet. 2022 Jan;260-261:30-36. doi: 10.1016/j.cancergen.2021.11.004. Epub 2021 Nov 15.
2
Identification of candidate cancer predisposing variants by performing whole-exome sequencing on index patients from BRCA1 and BRCA2-negative breast cancer families.通过对 BRCA1 和 BRCA2 阴性乳腺癌家族的索引患者进行全外显子组测序,鉴定候选癌症易感变异。
BMC Cancer. 2019 Apr 4;19(1):313. doi: 10.1186/s12885-019-5494-7.
3
Mutation analysis and characterization of ATR sequence variants in breast cancer cases from high-risk French Canadian breast/ovarian cancer families.来自高危法裔加拿大乳腺癌/卵巢癌家族的乳腺癌病例中ATR序列变异的突变分析与特征描述
BMC Cancer. 2006 Sep 29;6:230. doi: 10.1186/1471-2407-6-230.
4
Tumor sequencing is useful to refine the analysis of germline variants in unexplained high-risk breast cancer families.肿瘤测序有助于完善对不明原因的高风险乳腺癌家族中种系变异的分析。
Breast Cancer Res. 2020 Apr 15;22(1):36. doi: 10.1186/s13058-020-01273-y.
5
Clustering of known low and moderate risk alleles rather than a novel recessive high-risk gene in non-BRCA1/2 sib trios affected with breast cancer.在受乳腺癌影响的非 BRCA1/2 同胞三家中,已知的低风险和中风险等位基因聚集,而不是新的隐性高风险基因。
Int J Cancer. 2020 Nov 15;147(10):2708-2716. doi: 10.1002/ijc.33039. Epub 2020 May 30.
6
Whole-exome sequencing of Finnish hereditary breast cancer families.芬兰遗传性乳腺癌家族的全外显子组测序
Eur J Hum Genet. 2016 Jan;25(1):85-93. doi: 10.1038/ejhg.2016.141. Epub 2016 Oct 26.
7
Identification of a novel germline frameshift mutation p.D300fs of PMS1 in a patient with hepatocellular carcinoma: A case report and literature review.肝细胞癌患者中PMS1基因一种新的种系移码突变p.D300fs的鉴定:一例病例报告及文献综述
Medicine (Baltimore). 2020 Jan;99(5):e19076. doi: 10.1097/MD.0000000000019076.
8
Family specific genetic predisposition to breast cancer: results from Tunisian whole exome sequenced breast cancer cases.家族特异性乳腺癌遗传易感性:来自突尼斯全外显子组测序乳腺癌病例的结果。
J Transl Med. 2018 Jun 7;16(1):158. doi: 10.1186/s12967-018-1504-9.
9
Exonic sequencing and MLH3 gene expression analysis of breast cancer patients.对乳腺癌患者进行外显子测序和 MLH3 基因表达分析。
Cell Mol Biol (Noisy-le-grand). 2021 Nov 25;67(3):35-43. doi: 10.14715/cmb/2021.67.3.5.
10
Germline EMSY sequence alterations in hereditary breast cancer and ovarian cancer families.胚系 EMSY 序列改变与遗传性乳腺癌和卵巢癌家族相关。
BMC Cancer. 2017 Jul 24;17(1):496. doi: 10.1186/s12885-017-3488-x.

引用本文的文献

1
Germline testing of Iranian families suspected of Lynch syndrome: molecular characterization and current surveillance of families with pathogenic variants in MSH2 , MSH6 , and PMS2.对疑似林奇综合征的伊朗家庭进行种系检测:MSH2、MSH6和PMS2基因致病性变异家庭的分子特征及当前监测情况
Eur J Cancer Prev. 2025 Jul 1;34(4):349-356. doi: 10.1097/CEJ.0000000000000916. Epub 2024 Oct 22.